|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/198 | (2006.01) |
| A61K 31/198 | (2013.01) | ||
| A61P 25/04 | (2006.01) | ||
| A61P 25/04 | (2018.01) | ||
| Y02A 50/30 | (2018.01) |
| (11) | Patento numeris | 3598971 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19196366.9 |
| Europos patento paraiškos padavimo data | 2014-01-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-01-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-03-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201361849191 P | 2013-01-22 | US |
| (72) |
Snodgrass, Ralph H. , US
Cato, Allen E. , US
Hicklin, Jack S. , US
|
| (73) |
Vistagen Therapeutics, Inc. ,
343 Allerton Avenue, South San Francisco, CA 94080,
US
|
| (54) | DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLOROKYNURENINE |
| DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLOROKYNURENINE |